MiMARK

Barcelona, Spain

MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.

$394K raised

Sep 2025

Seed

Top Investors

InvereadyCDTI Innovación's INNVIERTE programEIC AcceleratorClave CapitalPharmStars

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MiMARK raised?

MiMARK has raised $394K in total funding. The most recent round was Seed. The last funding was announced in September 2025.

Who are MiMARK's investors?

MiMARK's investors include Inveready, CDTI Innovación's INNVIERTE program, EIC Accelerator, Clave Capital, PharmStars.

Where is MiMARK headquartered?

MiMARK is headquartered in Barcelona, Spain.

What does MiMARK do?

MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.

What stage is MiMARK at?

MiMARK is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 17, 2025.

MLA

"MiMARK — Funding & Investors." VCBacked, September 17, 2025, https://www.vcbacked.co/company/mimark. Accessed June 4, 2026.

APA

VCBacked. (2025). MiMARK — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/mimark

Wikipedia (cite web)

{{cite web |title=MiMARK — Funding & Investors |url=https://www.vcbacked.co/company/mimark |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 17, 2025.